DENVER, July 21, 2021 /PRNewswire/ -- Akerna
(Nasdaq: KERN), an enterprise software, leading compliance
technology provider, and developer of the cannabis industry's first
seed-to-sale enterprise resource planning (ERP) software technology
(MJ Platform®) today announced the release of its second annual
mid-year review.
This report highlights the state of the ever-changing and emerging
cannabis industry.
This report highlights the state of the ever-changing and
emerging cannabis industry. It takes a deep dive into cannabis
operators, ancillary cannabis, capital, new markets, consumer
shopping trends, and corporate social responsibility as it relates
to the cannabis industry.
You can access the report here.
Cannabis Industry Mid-Year Review Sections + Authors:
Intro: Jessica
Billingsley, Chief Executive Officer and Chairman of the
Board, Akerna
Cannabis Markets: Trends and Forecasting: Scott Sozio, Head of Corporate Development and
Board Member, Akerna
States are Recognizing the Economic Opportunity of
Cannabis: Sheri Springer,
Director of Service Sales, Akerna
Data Snapshot: Cannabis Consumer Spending and Trends:
James Ahrendt, Business Intelligence
Architect, Akerna
Cannabis and Corporate Social Responsibility:
Missi Woolridge, Marketing &
Community Engagement Specialist, Akerna
"We carefully curate this data and research-based report for
anyone interested in gaining a better understanding of the
fastest-growing industry in the world," says Jessica Billingsley, Akerna Chief Executive
Officer. "You will find value in this report whether you are a
business owner looking to make data-driven decisions, an investor
looking to learn more about the promising cannabis industry, or a
consumer interested in learning more about how the cannabis
industry works to safely deliver the products you consume."
About Akerna
Akerna (Nasdaq: KERN) is an enterprise
software company focused on compliantly serving the cannabis, hemp,
and CBD industries. Based in Denver,
Colorado, the Company's mission is to create the world's
most transparent and accountable supply chain by building a
cannabis technology ecosystem connecting data points across the
global cannabis supply chain from seed to sale to self. First
launched in 2010, Akerna has tracked more than $20 billion in cannabis sales to date and was the
first cannabis software company listed on Nasdaq.
Using connected data and information to propel the cannabis
industry forward, Akerna empowers businesses, governments,
patients, and consumers to make smart decisions. The Company's
cornerstone technology, MJ Platform, the world's leading
infrastructure as a service platform, powers retailers,
manufacturers, brands, distributors, and cultivators. Akerna also
offers a complete suite of professional consulting services and
data analytics for businesses as well as solo sciences, MJ Freeway,
Leaf Data Systems, Trellis, Ample Organics and Viridian
Sciences.
About MJ Freeway
MJ Freeway is more than software as a service. Its flagship
solution, MJ Platform, includes Platform Insights. Now operators,
investors, and regulators can access the industry's largest and
most statistically relevant database to drive data-driven business
decisions.
Platform Insights provides:
- The greatest statistical relevance across countries
- Normalized data (not farmed from various disparate POS
platforms)
- Full cannabis supply chain data
- Business insights founded in category management
methodology
Platform Insights can eliminate the guesswork and provide
answers to questions like:
- What is the gross margin return on inventory?
- What SKUs should be carried?
- How do basket adjacencies influence discounting and retention
strategies?
- What does a medical market look like a year
Click here for more information about
MJ Platform.
Forward-Looking Statements
Certain statements made in this release and any accompanying
statements by management are "forward-looking statements" within
the meaning of the "safe harbor" provisions of the United States
Private Securities Litigation Reform Act of 1995. When used in this
press release, the words "estimates," "projected," "expects,"
"anticipates," "forecasts," "plans," "intends," "believes,"
"seeks," "may," "will," "should," "future," "propose" and
variations of these words or similar expressions (or the negative
versions of such words or expressions) are intended to identify
forward-looking statements. Such forward-looking statements include
but are not limited to statements regarding the potential of adding
Barry Fishman to the board, which is
subject to the vote of stockholders at the Company's 2021 annual
meeting, the potential benefits of adding Barry Fishman to the board, Akerna's future
business plans, Akerna's potential business strengths in the market
and any other statements expressing the views of Akerna's
management on future business results or strategy. These
forward-looking statements are not guarantees of future
performance, conditions or results, and involve a number of
significant known and unknown risks, uncertainties, assumptions and
other important factors, many of which are outside Akerna's
control, that could cause actual results or outcomes (including,
without limitation, the results of Akerna's contracts, strategic
initiatives, and business plans as described herein) to differ
materially from those discussed in the forward-looking statements.
Important factors, among others that may affect actual results or
outcomes, include (i) Akerna's ability to recognize the anticipated
benefits of being a public company, (ii) competition, (iii)
Akerna's ability to grow and manage growth profitably, (iv)
Akerna's ability to maintain relationships with customers and
suppliers and retain its management and key employees, (v) costs
related to being a public company, (vi) changes in applicable laws
or regulations, (vii) Akerna's ability to identify, complete and
integrate acquisitions, including Viridian, and achieve expected
synergies and operating efficiencies in connection with acquired
businesses, (viii) and other risks and uncertainties disclosed from
time to time in Akerna's filings with the U.S. Securities and
Exchange Commission, including those under "Risk Factors" therein.
Actual results, performance, or achievements may differ materially,
and potentially adversely, from any projections and forward-looking
statements and the assumptions on which those vary from
forward-looking statements are based. There can be no assurance
that the data contained herein is reflective of future performance
to any degree. You are cautioned not to place undue reliance on
forward-looking statements as a predictor of future performance as
projected financial and other information, are based on estimates
and assumptions that are inherently subject to various significant
risks, uncertainties and other factors, many of which are beyond
Akerna's control. All information herein speaks only as of the date
hereof, in the case of information about Akerna, or the date of
such information, in the case of information from persons other
than Akerna. Akerna undertakes no duty to update or revise the
information contained herein. Forecasts and estimates regarding
Akerna's industry and end markets are based on sources believed to
be reliable; however, there can be no assurance these forecasts and
estimates will prove accurate in whole or in part.
![(PRNewsfoto/Akerna) (PRNewsfoto/Akerna)](https://mma.prnewswire.com/media/1196301/Akerna_Logo.jpg)
View original content to download
multimedia:https://www.prnewswire.com/news-releases/akerna-releases-2021-cannabis-industry-mid-year-review-301338318.html
SOURCE Akerna